ANAB
Price
$20.42
Change
-$1.16 (-5.38%)
Updated
Apr 23 closing price
Capitalization
661.79M
14 days until earnings call
HRMY
Price
$28.90
Change
-$0.28 (-0.96%)
Updated
Apr 23 closing price
Capitalization
1.67B
12 days until earnings call
Ad is loading...

ANAB vs HRMY

Header iconANAB vs HRMY Comparison
Open Charts ANAB vs HRMYBanner chart's image
AnaptysBio
Price$20.42
Change-$1.16 (-5.38%)
Volume$641.17K
Capitalization661.79M
Harmony Biosciences Holdings
Price$28.90
Change-$0.28 (-0.96%)
Volume$662.2K
Capitalization1.67B
ANAB vs HRMY Comparison Chart
Loading...
ANAB
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
HRMY
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
View a ticker or compare two or three
VS
ANAB vs. HRMY commentary
Apr 24, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is ANAB is a Buy and HRMY is a StrongBuy.

Ad is loading...
COMPARISON
Comparison
Apr 24, 2025
Stock price -- (ANAB: $20.40 vs. HRMY: $28.88)
Brand notoriety: ANAB and HRMY are both not notable
Both companies represent the Biotechnology industry
Current volume relative to the 65-day Moving Average: ANAB: 75% vs. HRMY: 86%
Market capitalization -- ANAB: $661.79M vs. HRMY: $1.67B
ANAB [@Biotechnology] is valued at $661.79M. HRMY’s [@Biotechnology] market capitalization is $1.67B. The market cap for tickers in the [@Biotechnology] industry ranges from $266.85B to $0. The average market capitalization across the [@Biotechnology] industry is $2.09B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

ANAB’s FA Score shows that 0 FA rating(s) are green whileHRMY’s FA Score has 0 green FA rating(s).

  • ANAB’s FA Score: 0 green, 5 red.
  • HRMY’s FA Score: 0 green, 5 red.
According to our system of comparison, HRMY is a better buy in the long-term than ANAB.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

ANAB’s TA Score shows that 5 TA indicator(s) are bullish while HRMY’s TA Score has 5 bullish TA indicator(s).

  • ANAB’s TA Score: 5 bullish, 4 bearish.
  • HRMY’s TA Score: 5 bullish, 4 bearish.
According to our system of comparison, both ANAB and HRMY are a good buy in the short-term.

Price Growth

ANAB (@Biotechnology) experienced а +7.03% price change this week, while HRMY (@Biotechnology) price change was +3.36% for the same time period.

The average weekly price growth across all stocks in the @Biotechnology industry was +8.04%. For the same industry, the average monthly price growth was -8.89%, and the average quarterly price growth was -12.57%.

Reported Earning Dates

ANAB is expected to report earnings on Aug 11, 2025.

HRMY is expected to report earnings on Aug 12, 2025.

Industries' Descriptions

@Biotechnology (+8.04% weekly)

Biotechnology involves genetic or protein engineering to produce medicines/therapies for treating and preventing ailments. The industry also provides crucial ingredients for diagnostics. This multi-billion-dollar industry is heavily focused on research and development, as companies attempt to continually come up with cutting-edge solutions for health. New discoveries for the treatment of diseases provide opportunities for growth for a company in this industry. Discoveries, however, must pass the regulatory approval from the U.S. Food and Drug Administration (FDA) before they can make it to markets. Amgen Inc., Gilead Sciences, Inc. and Celgene Corporation are examples of companies in this industry.

SUMMARIES
Loading...
FUNDAMENTALS
Fundamentals
HRMY($1.68B) has a higher market cap than ANAB($662M). ANAB YTD gains are higher at: 54.079 vs. HRMY (-16.071). HRMY has higher annual earnings (EBITDA): 233M vs. ANAB (-92.74M). HRMY has more cash in the bank: 467M vs. ANAB (385M). ANAB has less debt than HRMY: ANAB (16M) vs HRMY (179M). HRMY has higher revenues than ANAB: HRMY (715M) vs ANAB (91.3M).
ANABHRMYANAB / HRMY
Capitalization662M1.68B40%
EBITDA-92.74M233M-40%
Gain YTD54.079-16.071-336%
P/E RatioN/A11.63-
Revenue91.3M715M13%
Total Cash385M467M82%
Total Debt16M179M9%
FUNDAMENTALS RATINGS
ANAB: Fundamental Ratings
ANAB
OUTLOOK RATING
1..100
21
VALUATION
overvalued / fair valued / undervalued
1..100
84
Overvalued
PROFIT vs RISK RATING
1..100
75
SMR RATING
1..100
98
PRICE GROWTH RATING
1..100
40
P/E GROWTH RATING
1..100
67
SEASONALITY SCORE
1..100
50

Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.

TECHNICAL ANALYSIS
Technical Analysis
ANABHRMY
RSI
ODDS (%)
Bearish Trend 1 day ago
88%
Bullish Trend 1 day ago
85%
Stochastic
ODDS (%)
Bearish Trend 1 day ago
79%
Bearish Trend 1 day ago
81%
Momentum
ODDS (%)
Bullish Trend 1 day ago
84%
Bullish Trend 1 day ago
78%
MACD
ODDS (%)
Bullish Trend 1 day ago
73%
Bullish Trend 1 day ago
70%
TrendWeek
ODDS (%)
Bullish Trend 1 day ago
78%
Bullish Trend 1 day ago
74%
TrendMonth
ODDS (%)
Bullish Trend 1 day ago
77%
Bearish Trend 1 day ago
77%
Advances
ODDS (%)
Bullish Trend 3 days ago
77%
Bullish Trend 3 days ago
76%
Declines
ODDS (%)
Bearish Trend 15 days ago
82%
Bearish Trend 9 days ago
76%
BollingerBands
ODDS (%)
Bearish Trend 1 day ago
85%
Bullish Trend 1 day ago
84%
Aroon
ODDS (%)
Bullish Trend 1 day ago
85%
Bearish Trend 1 day ago
76%
View a ticker or compare two or three
Ad is loading...
ANAB
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
HRMY
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
MFs / NAMEPrice $Chg $Chg %
MCRFX13.35N/A
N/A
BlackRock Mid-Cap Value Investor C
JABAX42.74N/A
N/A
Janus Henderson Balanced T
EGWRX15.37N/A
N/A
Allspring Discovery Small Cap Gr R6
NDVVX15.92N/A
N/A
MFS New Discovery Value R6
MSTSX10.37N/A
N/A
Morningstar Global Opportunistic Equity

ANAB and

Correlation & Price change

A.I.dvisor indicates that over the last year, ANAB has been loosely correlated with CLRB. These tickers have moved in lockstep 45% of the time. This A.I.-generated data suggests there is some statistical probability that if ANAB jumps, then CLRB could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To ANAB
1D Price
Change %
ANAB100%
-5.47%
CLRB - ANAB
45%
Loosely correlated
+2.48%
ADCT - ANAB
41%
Loosely correlated
+4.88%
QTTB - ANAB
41%
Loosely correlated
-1.05%
HRMY - ANAB
39%
Loosely correlated
-1.03%
AMRN - ANAB
38%
Loosely correlated
-1.24%
More

HRMY and

Correlation & Price change

A.I.dvisor indicates that over the last year, HRMY has been loosely correlated with SNBIF. These tickers have moved in lockstep 52% of the time. This A.I.-generated data suggests there is some statistical probability that if HRMY jumps, then SNBIF could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To HRMY
1D Price
Change %
HRMY100%
-1.03%
SNBIF - HRMY
52%
Loosely correlated
N/A
SAGE - HRMY
40%
Loosely correlated
-0.78%
ANAB - HRMY
37%
Loosely correlated
-5.47%
CYTK - HRMY
37%
Loosely correlated
+0.50%
AXON - HRMY
31%
Poorly correlated
+3.82%
More